Publications
2023
- Accidents vasculaires cérébraux suivant l’administration d’un vaccin contre la COVID-19
- Zona survenu à la suite de la vaccination contre la COVID-19 au Québec
- Paralysie de Bell survenue à la suite de la vaccination contre la COVID-19 au Québec
- Manifestations cliniques indésirables à la suite de la vaccination de base contre la COVID-19 déclarées au système de surveillance passive du Québec
- Surveillance active de la sécurité des trois premières doses de vaccin contre la COVID-19 au Québec
- Administration of COVID-19 booster doses: Recommendations for winter and spring 2023
- Administration de doses de rappel du vaccin contre la COVID-19 : recommandations pour l’hiver et le printemps 2023
2022
- Administration d’une dose de vaccin bivalent aux personnes vaccinées avec le vaccin monovalent contre la COVID-19 depuis le 15 août 2022
- Vaccination contre l’influenza et la COVID-19 à l’automne 2022
- Stratégie vaccinale contre la COVID-19 à préconiser au Québec en 2022 et pertinence d’une 2e dose de rappel pour certains groupes vulnérables
- Administration des doses subséquentes d’un vaccin contre la COVID-19 chez les personnes ayant développé une péricardite ou une myocardite
- Enquête épidémiologique sur les travailleurs de la santé atteints par la COVID-19
- Vaccination contre l’hépatite virale A suite à une éclosion à Nunavik
Publications
2018
- Role of egg-adaptation mutations in low influenza A(H3N2) vaccine effectiveness during the 2012-13 season
- Ecological Fallacy, Nonspecific Outcomes, and the Attribution of Disproportionate Vaccine Benefits
- Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018
- Absence of association between Guillain-Barré syndrome hospitalizations and HPV-vaccine
- Short-term safety of 4CMenB vaccine during a mass meningococcal B vaccination campaign in Quebec, Canada
2017
- Selection bias in the assessment of frailty and its role in influenza vaccine effectiveness evaluation among elderly adults.
- Risk of Recurrence of Adverse Events Following Immunization: A Systematic Review.
- Adverse events following live-attenuated intranasal influenza vaccination of children with cystic fibrosis: Results from two influenza seasons.
- Evaluation of the New World Health Organization Case Definition of Severe Acute Respiratory Infection for Influenza Surveillance During the Peak Weeks of Two Influenza Seasons in Quebec, Canada.
- Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010-2011 to 2015-2016, Canada.
- Reply to Chung et al.
- Viral interference and the live-attenuated intranasal influenza vaccine: Results from a pediatric cohort with cystic fibrosis.
- Reduced antibody response to infant measles vaccination: effects based on type and timing of the first vaccine dose persist after the second dose.
- Clinical Approach Used in Medical Consultations for Allergic-Like Events Following Immunization: Case Series Report in Relation to Practice Guidelines.
- RE: "Detectable Risks in Studies of the Fetal Benefits of Maternal Influenza Vaccination"